iRadimed Q3 revenue up 23% to $13.4M; GAAP EPS $0.27; guides Q4 rev $14.1-14.8M

IRADIMED CORP

2022-Q3 EPS reported $0.72 revenue$38,439,551

Q3 revenue $13.4M (+23% YoY), operating income $4.1M (+32%), GAAP EPS $0.27 (+35%).
Non-GAAP net income $3.7M (excl. $0.3M stock comp); nine-month non-GAAP EPS $0.78 vs $0.50.
Gross margin improved to 78.6% from 77.1%; operating cash flow $3.9M in Q3.
Q4 guidance: revenue $14.1-14.8M, GAAP EPS $0.23-0.28, non-GAAP EPS $0.25-0.30.
CEO cites strong bookings and backlog; purchased 27 acres in Orlando for future HQ, tripling space.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

IRADIMED CORP reported financial results for the third quarter ended September 30, 2022.

Period: the third quarter ended September 30, 2022
Result: reported results

Exact text from the filing

On November 3, 2022, iRadimed Corporation issued a press release (the “Press Release”) announcing its financial results for the third quarter ended September 30, 2022.

View on SEC.gov

Browse all earnings releases →

IRADIMED CORP filing history →

Source: SEC EDGAR

accession 0000898432-22-000631

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.